Jane Street’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Jane Street’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-51,083	Closed	-$35.7K	–	9881
2023 Q1	$35.7K	Sell	51,083 -80,486	-61%	-$65.2K	﹤0.01%	8534
2022 Q4	$108K	Buy	+131,569	New	+$130K	﹤0.01%	8049
2022 Q1	–	Sell	-14,085	Closed	-$67K	–	11301
2021 Q4	$67K	Sell	14,085 -21,604	-61%	-$139K	﹤0.01%	9415
2021 Q3	$270K	Sell	35,689 -38,528	-52%	-$247K	﹤0.01%	8386
2021 Q2	$554K	Sell	74,217 -7,696	-9%	-$59.3K	﹤0.01%	7043
2021 Q1	$639K	Buy	81,913 +63,357	+341%	+$633K	﹤0.01%	6350
2020 Q4	$171K	Sell	18,556 -21,249	-53%	-$185K	﹤0.01%	7027
2020 Q3	$275K	Buy	+39,805	New	+$241K	﹤0.01%	6013
2019 Q3	–	Sell	-29,111	Closed	-$82K	–	5949
2019 Q2	$82K	Buy	+29,111	New	+$116K	﹤0.01%	4889

Other funds holding SURF

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's SURF Position: Q2 2023 in Review

Jane Street sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 51,083 shares — an estimated $35.7K sold.

Jane Street first reported a position in SURF in Q2 2019 and held it in 9 quarters. The position peaked at $639K in Q1 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

Jane Street reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Jane Street sold 51,083 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $35.7K.
Jane Street first reported a position in Surface Oncology, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Jane Street's Surface Oncology, Inc. Common Stock position peaked at $639K in Q1 2021.
61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.